Immunomodulation of Skin Cancer

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Jul 14

PMID 37445639

Authors

Nabiha Yusuf

Affiliations

Soon will be listed here.

Abstract

Skin cancer represents a major public health issue with a tremendous cost to healthcare systems in the United States and worldwide [...].

Citing Articles

Topical Immunotherapy for Actinic Keratosis and Field Cancerization.

Masferrer L, Gracia Cazana T, Bernad Alonso I, Alvarez-Salafranca M, Almenara Blasco M, Gallego Rentero M Cancers (Basel). 2024; 16(6).

PMID: 38539468 PMC: 10969398. DOI: 10.3390/cancers16061133.

References

Berneburg M, Lowe J, Nardo T, Araujo S, Fousteri M, Green M . UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome. EMBO J. 2000; 19(5):1157-66. PMC: 305654. DOI: 10.1093/emboj/19.5.1157. View

Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D . Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017; 7(2):1-6. PMC: 5424654. DOI: 10.5826/dpc.0702a01. View

Azumi J, Takeda T, Shimada Y, Zhuang T, Tokuji Y, Sakamoto N . Organogermanium THGP Induces Differentiation into M1 Macrophages and Suppresses the Proliferation of Melanoma Cells via Phagocytosis. Int J Mol Sci. 2023; 24(3). PMC: 9915250. DOI: 10.3390/ijms24031885. View

Strashilov S, Yordanov A . Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances. Int J Mol Sci. 2021; 22(12). PMC: 8232613. DOI: 10.3390/ijms22126395. View

Oronsky B, Carter C, Reid T, Brinkhaus F, Knox S . Just eat it: A review of CD47 and SIRP-α antagonism. Semin Oncol. 2020; 47(2-3):117-124. DOI: 10.1053/j.seminoncol.2020.05.009. View

Najafi M, Goradel N, Farhood B, Salehi E, Shabani Nashtaei M, Khanlarkhani N . Macrophage polarity in cancer: A review. J Cell Biochem. 2018; 120(3):2756-2765. DOI: 10.1002/jcb.27646. View

Farhana A . Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects. Int J Mol Sci. 2023; 24(4). PMC: 9959821. DOI: 10.3390/ijms24043493. View

Rangwala S, Tsai K . Roles of the immune system in skin cancer. Br J Dermatol. 2011; 165(5):953-65. PMC: 3197980. DOI: 10.1111/j.1365-2133.2011.10507.x. View

Kumano N, Ishikawa T, Koinumaru S, Kikumoto T, Suzuki S, Nakai Y . Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57BL/6 (B6) mice. Tohoku J Exp Med. 1985; 146(1):97-104. DOI: 10.1620/tjem.146.97. View

10.

Sisirak V, Faget J, Gobert M, Goutagny N, Vey N, Treilleux I . Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res. 2012; 72(20):5188-97. DOI: 10.1158/0008-5472.CAN-11-3468. View

11.

Tabolacci C, De Vita D, Facchiano A, Bozzuto G, Beninati S, Failla C . Phytochemicals as Immunomodulatory Agents in Melanoma. Int J Mol Sci. 2023; 24(3). PMC: 9916941. DOI: 10.3390/ijms24032657. View

12.

Clifford J, Walch E, Yang X, Xu X, Alberts D, Clayman G . Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clin Cancer Res. 2002; 8(7):2067-72. View

13.

Tamura Y, Ito A, Wakamatsu K, Kamiya T, Torigoe T, Honda H . Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review. Int J Mol Sci. 2022; 23(12). PMC: 9223671. DOI: 10.3390/ijms23126457. View

14.

Fujimura T . Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers. Int J Mol Sci. 2022; 23(7). PMC: 8999844. DOI: 10.3390/ijms23074044. View

15.

Sherwani M, Ahmad I, Lewis M, Abdelgawad A, Rashid H, Yang K . Type I Interferons Enhance the Repair of Ultraviolet Radiation-Induced DNA Damage and Regulate Cutaneous Immune Suppression. Int J Mol Sci. 2022; 23(3). PMC: 8836948. DOI: 10.3390/ijms23031822. View